Evidence map›Paper›PMID 39622256›Full record

ArticleThe Lancet. Oncology2025

Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus.

Vincent J Cogliano, Emanuela Corsini, Agnès Fournier, Heather H Nelson, Consolato M Sergi, Alexandra M M Antunes, Elizabeth K Cahoon, Guosheng Chen, Talita Duarte-Salles, Eric Engels and 30 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Population-level cancer trends among solid organ transplant recipients in the United States during 1995-2021.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Vincent J CoglianoInternational Agency for Research on Cancer, Lyon, France.
Emanuela CorsiniInternational Agency for Research on Cancer, Lyon, France.
Agnès FournierInternational Agency for Research on Cancer, Lyon, France.
Heather H NelsonInternational Agency for Research on Cancer, Lyon, France.
Consolato M SergiInternational Agency for Research on Cancer, Lyon, France.
Alexandra M M AntunesInternational Agency for Research on Cancer, Lyon, France.
Elizabeth K CahoonInternational Agency for Research on Cancer, Lyon, France.
Guosheng ChenInternational Agency for Research on Cancer, Lyon, France.
Talita Duarte-SallesInternational Agency for Research on Cancer, Lyon, France.
Eric EngelsInternational Agency for Research on Cancer, Lyon, France.
Jingqi FuInternational Agency for Research on Cancer, Lyon, France.
Dori GermolecInternational Agency for Research on Cancer, Lyon, France.
Reza GhiasvandInternational Agency for Research on Cancer, Lyon, France.
Blánaid HicksInternational Agency for Research on Cancer, Lyon, France.
Bertrand J Jean-ClaudeInternational Agency for Research on Cancer, Lyon, France.
Gopabandhu JenaInternational Agency for Research on Cancer, Lyon, France.
Catharina M LercheInternational Agency for Research on Cancer, Lyon, France.
Xilin LiInternational Agency for Research on Cancer, Lyon, France.
Angela LupattelliInternational Agency for Research on Cancer, Lyon, France.
Thomas P OngInternational Agency for Research on Cancer, Lyon, France.
Libia VegaInternational Agency for Research on Cancer, Lyon, France.
Diana R WithrowInternational Agency for Research on Cancer, Lyon, France.
Alistair B A BoxallInternational Agency for Research on Cancer, Lyon, France.
Lamia Benbrahim-TallaaInternational Agency for Research on Cancer, Lyon, France.
Aline de ContiInternational Agency for Research on Cancer, Lyon, France.
Andrew KunzmannInternational Agency for Research on Cancer, Lyon, France.
Elisa PasqualInternational Agency for Research on Cancer, Lyon, France.
Roland WedekindInternational Agency for Research on Cancer, Lyon, France.
Xiaobei DengInternational Agency for Research on Cancer, Lyon, France.
Yahya Mahamat-SalehInternational Agency for Research on Cancer, Lyon, France.
Azam MajidiInternational Agency for Research on Cancer, Lyon, France.
Laia Peruchet-NorayInternational Agency for Research on Cancer, Lyon, France.
Julia Rezende Da SilvaInternational Agency for Research on Cancer, Lyon, France.
Eero SuonioInternational Agency for Research on Cancer, Lyon, France.
Susana ViegasInternational Agency for Research on Cancer, Lyon, France.
Yue ZhaiInternational Agency for Research on Cancer, Lyon, France.
Heidi MattockInternational Agency for Research on Cancer, Lyon, France.
Caterina FacchinInternational Agency for Research on Cancer, Lyon, France.
Mary K Schubauer-BeriganInternational Agency for Research on Cancer, Lyon, France; International Agency for Research on Cancer, Lyon, France.
Federica MadiaInternational Agency for Research on Cancer, Lyon, France; International Agency for Research on Cancer, Lyon, France.

Funding

IARC Monographs on the Identification of Carcinogenic Hazards to HumansR01CA033193 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI SCHUBAUER-BERIGAN, MARY K. · 2021 to 2025
$4.9M
NCI NIH HHS R01 CA033193World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39622256
PMCPMC12174844

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.